Safety and efficacy of melatonin as an adjuvant therapy in COVID-19 patients: Systematic review and meta-analysis

Author:

Mohamed Taha AmiraORCID,Adel Abdelkader Saed Sara,Hossam-Eldin Moawad Mostafa,Abd El-Tawab Moawad Wesam,Al-hejazi Tala,Mousa Yosra,Sharma Ramaswamy,Reiter Russel J.

Publisher

Elsevier BV

Subject

General Medicine

Reference47 articles.

1. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease;Struyf;Cochrane Database Syst Rev,2020

2. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues;Li;Infect Dis Poverty,2020

3. The COVID-19 cytokine storm; what we know so far;Ragab;Front Immunol,2020

4. A pilot study on controlling coronavirus disease 2019 (COVID-19) inflammation using melatonin supplement;Alizadeh;Iran J Allergy, Asthma Immunol,2021

5. High dose melatonin as an adjuvant therapy in intubated patients with COVID-19: a randomized clinical trial;Alizadeh;J Taibah Univer Med Sci,2022

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3